• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢哌酮和拉氧头孢的活性及对β-内酰胺酶的敏感性。与其他头孢菌素的比较。

Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.

作者信息

Mouton R P, Bongaerts G P, van Gestel M, Bruggeman-Ogle K M

出版信息

Chemotherapy. 1981;27(5):318-24. doi: 10.1159/000237999.

DOI:10.1159/000237999
PMID:6455258
Abstract

Comparison of the activity of cefoperazone, cefamandole, cefotaxime, cephalothin and moxalactam against Enterobacteriaceae showed cefoperazone to be twofold (Escherichia coli, Klebsiella) to eigthfold (Enterobacter) more active than cefamandole. The lowes MIC values were found for cefotaxime (0.03 - 0.25 microgram/ml) followed by moxalactam (0.06 - 0.25 microgram/ml). Cefoperazone stood out in activity against Pseudomonas aeruginosa (MIC50 4 microgram/ml). Cephalothin resistance affected the MIC values of cefoperazone and moxalactam only to a small degree. From beta-lactamase susceptibility studies it was concluded that cefoperazone may be hydrolyzed by TEM type beta-lactamases, but that the cephalosporinases (class I) and the chromosomal broad-spectrum beta-lactamases (class IV) only have little effect on this antibiotic. Moxalactam was not degraded by any of the beta-lactamase preparations tested.

摘要

头孢哌酮、头孢孟多、头孢噻肟、头孢噻吩和拉氧头孢对肠杆菌科细菌活性的比较表明,头孢哌酮的活性比头孢孟多高两倍(大肠杆菌、克雷伯菌属)至八倍(肠杆菌属)。头孢噻肟的最低抑菌浓度(MIC)值最低(0.03 - 0.25微克/毫升),其次是拉氧头孢(0.06 - 0.25微克/毫升)。头孢哌酮对铜绿假单胞菌的活性突出(MIC50为4微克/毫升)。头孢噻吩耐药性仅对头孢哌酮和拉氧头孢的MIC值有较小影响。从β-内酰胺酶敏感性研究得出的结论是,头孢哌酮可能被TEM型β-内酰胺酶水解,但头孢菌素酶(I类)和染色体广谱β-内酰胺酶(IV类)对这种抗生素影响很小。拉氧头孢未被所测试的任何一种β-内酰胺酶制剂降解。

相似文献

1
Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.头孢哌酮和拉氧头孢的活性及对β-内酰胺酶的敏感性。与其他头孢菌素的比较。
Chemotherapy. 1981;27(5):318-24. doi: 10.1159/000237999.
2
[Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].头孢哌酮、头孢噻肟、拉氧头孢及头孢曲松的抗菌活性及对β-内酰胺酶稳定性的比较
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol. 1982 Jun;252(2):208-21.
3
Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.8种头孢菌素对109株淋病奈瑟菌和60株脑膜炎奈瑟菌的体外活性比较
Chemotherapy. 1981;27 Suppl 1:19-24. doi: 10.1159/000238024.
4
Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.羟羧氧酰胺菌素及其他选定头孢菌素抗生素的体外活性及β-内酰胺酶稳定性比较
Arzneimittelforschung. 1981;31(8):1290-5.
5
Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.氧杂β-内酰胺类LY127935、头孢噻肟、头孢哌酮、头孢孟多和替卡西林对多重耐药革兰氏阴性杆菌的比较活性。
Antimicrob Agents Chemother. 1980 Feb;17(2):273-9. doi: 10.1128/AAC.17.2.273.
6
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.头孢哌酮、头孢噻肟、拉氧头孢(LY127935)、阿洛西林、美洛西林及其他β-内酰胺类抗生素对淋病奈瑟菌和流感嗜血杆菌的体外抗菌活性,包括产β-内酰胺酶菌株。
Antimicrob Agents Chemother. 1980 Apr;17(4):757-61. doi: 10.1128/AAC.17.4.757.
7
Comparative in vitro activity of first, second and third generation cephalosporins.第一代、第二代和第三代头孢菌素的体外活性比较
Acta Pathol Microbiol Scand B. 1981 Aug;89(4):221-5. doi: 10.1111/j.1699-0463.1981.tb00180_89b.x.
8
Susceptibility of ceftazidime and other cephalosporins to a range of beta-lactamases and their potential as inducing agents.头孢他啶及其他头孢菌素对一系列β-内酰胺酶的敏感性及其作为诱导剂的潜力。
J Antimicrob Chemother. 1981 Sep;8 Suppl B:147-52. doi: 10.1093/jac/8.suppl_b.147.
9
Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.头孢哌酮、头孢噻肟、头孢磺啶、头孢他啶、拉氧头孢和头孢曲松对铜绿假单胞菌的β-内酰胺酶稳定性及体外活性比较。
J Antimicrob Chemother. 1981 Oct;8(4):323-31. doi: 10.1093/jac/8.4.323.
10
The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.与其他β-内酰胺类抗生素相比,头孢替坦的活性及β-内酰胺酶稳定性。
Chemioterapia. 1985 Aug;4(4):271-7.

引用本文的文献

1
[N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].[N-甲脒基硫霉素:对β-内酰胺类抗生素或庆大霉素耐药细菌的体外活性]
Infection. 1982 Nov-Dec;10(6):361-70. doi: 10.1007/BF01642300.
2
Recognition and clinical significance of mechanisms of bacterial resistance to beta-lactams.细菌对β-内酰胺类抗生素耐药机制的认识及其临床意义
Antonie Van Leeuwenhoek. 1984;50(5-6):711-27. doi: 10.1007/BF02386236.
3
Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
拉氧头孢。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1983 Oct;26(4):279-333. doi: 10.2165/00003495-198326040-00001.